HIK:LON
Hikma Pharmaceuticals Plc
GBX 1,665.00
arrow_upward
+0.18%(+3.00) 1D
Oct 19, 4:35:06 PM GMT+1 · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HIK...
Open
GBX 1,662.00
High
GBX 1,667.00
Low
GBX 1,648.00
Mkt. cap
3.46B
Avg. vol.
474.53K
Volume
346.18K
Dividend
3.81%
Quarterly dividend
GBX 15.85
Ex-dividend date
Aug 13, 2026
P/E ratio
12.64
52-wk high
GBX 1,865.00
52-wk low
GBX 1,187.00
EPS
GBX 1.32
Shares outstanding
208.75M
No. of employees
10K
Open
GBX 1,662.00
High
GBX 1,667.00
Low
GBX 1,648.00
Mkt. cap
3.46B
Avg. vol.
474.53K
Volume
346.18K
Dividend
3.81%
Quarterly dividend
GBX 15.85
Ex-dividend date
Aug 13, 2026
P/E ratio
12.64
52-wk high
GBX 1,865.00
52-wk low
GBX 1,187.00
EPS
GBX 1.32
Shares outstanding
208.75M
No. of employees
10K
News stories
From web sources and news partners
Kalkine Media
·
10 hours ago
Blue-Chip Stock Hikma (LSE:HIK) Holds Full-Year Outlook: What It Means
ad-hoc-news.de
·
1 day ago
Hikma launches Fidaxomicin Tablets as Hikma stock awaits update
Profile
Hikma Pharmaceuticals plc is a Jordanian multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
About Hikma Pharmaceuticals Plc
CEO-
Employees9.5K
Founded1978
HeadquartersLondon, England, United Kingdom
SectorPharmaceutical industry
Websitehikma.com